Patents by Inventor Philippe A. Parone

Philippe A. Parone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158747
    Abstract: Compositions and methods for manufacturing induced immune regulatory cells comprising induced myeloid suppressive cells including MDSCs (myeloid-derived suppressor cells), dendritic cells, macrophages, and subpopulations thereof are provided. Also provided are methods and compositions for further modifying and modulating the induced immune regulatory cells to achieve enhanced therapeutic potential in treating autoimmune disorders, hematological malignancies, solid tumors, viral infections, neurodegenerative disorders, inflammatory conditions, or GvHD.
    Type: Application
    Filed: November 3, 2023
    Publication date: May 16, 2024
    Inventors: Philippe A. Parone, Robert S. Tacke, Bahram Valamehr, Daniel Shoemaker, Martin Hosking, Lisa Guerrettaz
  • Patent number: 11851677
    Abstract: Compositions and methods for manufacturing induced immune regulatory cells comprising induced myeloid suppressive cells including MDSCs (myeloid-derived suppressor cells), dendritic cells, macrophages, and subpopulations thereof are provided. Also provided are methods and compositions for further modifying and modulating the induced immune regulatory cells to achieve enhanced therapeutic potential in treating autoimmune disorders, hematological malignancies, solid tumors, viral infections, neurodegenerative disorders, inflammatory conditions, or GvHD.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: December 26, 2023
    Inventors: Philippe A. Parone, Robert S. Tacke, Bahram Valamehr, Daniel Shoemaker, Martin Hosking, Lisa Guerrettaz
  • Publication number: 20200102536
    Abstract: Compositions and methods for manufacturing induced immune regulatory cells comprising induced myeloid suppressive cells including MDSCs (myeloid-derived suppressor cells), dendritic cells, macrophages, and subpopulations thereof are provided. Also provided are methods and compositions for further modifying and modulating the induced immune regulatory cells to achieve enhanced therapeutic potential in treating autoimmune disorders, hematological malignancies, solid tumors, viral infections, neurodegenerative disorders, inflammatory conditions, or GvHD.
    Type: Application
    Filed: June 13, 2018
    Publication date: April 2, 2020
    Inventors: Philippe A. Parone, Robert S. Tacke, Bahram Valamehr, Daniel Shoemaker, Martin Hosking, Lisa Guerrettaz